Use of NOS inhibitor to expand hematopoietic stem cells

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43HL077058-01
Agency Tracking Number: HL077058
Amount: $192,938.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
ARGINOX PHARMACEUTICALS, INC., 120 CONSTITUTION DR, STE B, MENLO PARK, CA, 94025
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 PETER Krasnov
 (650) 324-5150
Business Contact
 KENNETH DRAZAN
Phone: (650) 324-5150
Email: drazan@arginox.com
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Hematopoietic cell-supported therapy is employed for a broad spectrum of malignancies and hematological disease. However, the approach is limited by the availability of hematopoietic stem cells; thus, the possibilit

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government